Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping.
暂无分享,去创建一个
M J Banda | D. Rappolee | Z. Werb | D. Mark | Z Werb | D A Rappolee | D Mark | D. Mark | M. J. Banda
[1] J. Mermod,et al. Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation , 1987, Cell.
[2] R. Ross,et al. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. , 1975, The American journal of pathology.
[3] G. I. Bell,et al. Sequences of liver cDNAs encoding two different mouse insulin-like growth factor I precursors. , 1986, Nucleic acids research.
[4] J. Folkman,et al. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. , 1984, Science.
[5] S. Gordon,et al. F4/80, a monoclonal antibody directed specifically against the mouse macrophage , 1981, European journal of immunology.
[6] R. A. Murphy,et al. Steroids and triiodothyronine reduce nerve growth factor concentrations in medium conditioned by L-929 fibroblasts. , 1986, Endocrinology.
[7] R. Eddy,et al. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines , 1986, Nature.
[8] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[9] K. Mullis,et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.
[10] Z. Werb,et al. Apoprotein E is synthesized and secreted by resident and thioglycollate- elicited macrophages but not by pyran copolymer- or bacillus Calmette- Guerin-activated macrophages , 1983, The Journal of experimental medicine.
[11] R. Derynck,et al. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. , 1986, Science.
[12] M. Sporn,et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Griffin,et al. Expression of the M-CSF (CSF-1) gene by human monocytes. , 1987, Blood.
[14] L M Wakefield,et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[15] G. Carpenter. Properties of the receptor for epidermal growth factor , 1984, Cell.
[16] A. Ullrich,et al. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor , 1983, Nature.
[17] J. Goldstein,et al. Atherosclerosis: Scavenger cell receptor shared , 1985, Nature.
[18] J M Davidson,et al. Sustained release of epidermal growth factor accelerates wound repair. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[19] E. Chen,et al. The murine transforming growth factor-beta precursor. , 1986, The Journal of biological chemistry.
[20] H. Shepard,et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.
[21] W. Wharton,et al. Mitogenic activity elaborated by macrophage‐like cell lines acts as competence factor(s) for BALB/c 3T3 cells , 1982, Journal of cellular physiology.
[22] C. Pert,et al. Bombesin in human and guinea pig alveolar macrophages. , 1986, Journal of immunology.
[23] K. Mullis,et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.
[24] Z. Werb,et al. Onset of apoprotein E secretion during differentiation of mouse bone marrow-derived mononuclear phagocytes , 1983, Journal of Cell Biology.
[25] W. Risau,et al. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[26] M. Brown,et al. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. White,et al. Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. , 1987, Science.
[28] R. Ross. The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.
[29] Gary R. Grotendorst,et al. Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity , 1986, Nature.
[30] P. Lomedico,et al. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli , 1984, Nature.
[31] S. Mizel. Interleukin l and T Cell Activation , 1982 .
[32] T. K. Hunt,et al. Oxygen tension regulates the expression of angiogenesis factor by macrophages. , 1983, Science.
[33] David C. Lee,et al. Cloning and sequence analysis of a cDNA for rat transforming growth factor-α , 1985, Nature.
[34] P. Morméde,et al. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. , 1985, Biochemical and biophysical research communications.
[35] R. Knobler,et al. Western and dot immunoblotting analysis of viral antigens and antibodies: Application to murine hepatitis virus , 1984, Journal of Immunological Methods.
[36] Z. Werb,et al. Endotoxin suppresses expression of apoprotein E by mouse macrophages in vivo and in culture. A biochemical and genetic study. , 1983, The Journal of biological chemistry.
[37] R. Ross,et al. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF , 1985, Cell.
[38] M. Sporn,et al. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. , 1987, Science.